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Introduction.
The larval stage of the common green bottle, Lucilia (Phaenicia) sericata (Diptera: Calliphoridae), is one of the few members of Diptera that can be applied clinically to chronic wounds (1) . Maggot debridement therapy (MDT) using L. sericata larvae is now considered a viable option for the treatment of certain chronic wounds (2) , with the secretions from L. sericata having been shown to possess a number of digestive proteases, including serine proteases (3, 4) and collagenase (5) , which contribute to the debridement of chronic wounds allowing healing to take place (6) .
Although in modern medicine, MDT is used primarily for the debridement of chronic wounds, there are other associated advantages which go beyond the removal of necrotic tissue. As far back as the Napoleonic wars, field hospitals began reporting soldiers with noninfected, maggot-infested battle wounds showing accelerated healing and no signs of infection (7) . While there is still much debate as to the precise mechanisms involved in wound healing, the antibacterial properties for L. sericata have been thoroughly investigated and many antibacterial factors described (8) (9) (10) (11) (12) (13) .
It had been suggested that some antimicrobial activity may be attributed to the process of debridement, during which ingested bacteria are eradicated as they pass through the alimentary tract of the maggot (14) . More recent investigations into this activity have focused on discerning the identities of the antibacterial components present in the excretions/secretions (ES) of L. sericata. Such investigations are driven in part by the emergence of microorganisms resistant to conventional therapies, such as methicillin resistant Staphylococcus aureus. Recent studies into L. sericata secretions using separation 4 techniques, such as ultrafiltration, have revealed the presence of two antibacterial moieties; one 0.5 -0.3 kDa, heat-stable, protease resistant antibacterial compound and a <0.5 kDa component with activity against MRSA (8) . These findings suggest that the inhibition/extermination of bacteria can occur outside the maggot digestive system and may contribute to their ability to thrive on carrion in nature (15) .
In their natural environment, maggots have to compete with several decomposers, including fungi, as well as bacteria. Although there is an extensive volume of literature available on the antibacterial properties of L. sericata larvae, the antifungal properties have attracted considerably less attention, comprising, to our knowledge thus far, of only three reports. One showing activity against the agricultural pathogens Fusarium sambucinum and Fusarium verticillioides (16) , another demonstrating activity of a novel antifungal peptide, lucimycin, against the agricultural pathogens F. graminearum and Phytophthora parasitica, along with some opportunistic fungal pathogens, including Aspergillus fumigatus and Candida albicans (17) and the other demonstrating activity against Trichophyton terrestre, a cause of some superficial fungal infections (18) .
Fungal infections which are unresponsive to conventional antifungal therapies are becoming an increasing problem in a clinical setting. Candida species for example represent a significant cause of morbidity in patients with chronic conditions (19) with Candida albicans accounting for >50% of fungal species isolated from infected wounds, with other species of Candida accounting for around 19% (20) . Identifying new antifungal agents which can be used in a clinical setting, perhaps systemically to treat fungal infections unresponsive to conventional therapy is therefore of growing importance. 6 Collection of L. sericata ES was modified from the method previously described by Bexfield et al., (8) as described in the supplementary methodology material.
Unless stated as L1, all experiments were undertaken using secretions collected from late L2/L3 larvae.
Size fractionation of larval secretions.
Fractionation of nES took place sequentially. Firstly, 5 ml aliquots of nES were filtered through an Amicon Ultra 10 kDa molecular weight cut off (MWCO) centrifugal filter (Millipore UK Ltd., Herefordshire, UK) at 4,000 g. Five hundred µl of sterile Milli-Q water were added to the retentant and spun for 15 minutes to ensure total volume (i.e. 5 ml) <10 kDa materials were filtered. The unfiltered ES was then reconstituted to its original volume in sterile Milli-Q water and retained as the >10 kDa ES fraction (ES >10 ). The filtrate was passed through a 0.5 kDa MWCO membrane (Sterlitech Corp., WA, USA) in an Amicon stirred ultrafiltration cell (Millipore UK Ltd., UK) under ≤75 PSI at 4 O C until approximately 0.5 -1 ml <10 kDa ES remained. This material was reconstituted to its original volume (5 ml) in sterile Milli-Q water and retained for testing as a 10-0.5 kDa ES fraction (ES 10-0.5 ). The filtered material was retained as a <0.5 kDa ES fraction (ES <0.5 ). All fractions were filter sterilised through a 0.2 µm filter and stored at -20 O C prior to analysis.
Detection of antifungal activity.
Colony forming unit (CFU) assay for the detection of antifungal activity.
To determine the antifungal activity of L. sericata ES, C. albicans was grown as previously described and prepared as recommended by the CLSI M27-A3 document and Optical density (OD) assay for the detection of antifungal activity.
The OD assay was a modification of the method originally described by Thomas et al., (21) 
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Survival Index (SI).
Antifungal activity was quantified using the survival index as described previously by ES <0.5 stability was also investigated after lyophilisation. Ten ml aliquots of sterile -ES <0.5 were placed in a 30 ml universal container and covered with punctured aluminium foil.
Samples were then frozen to -80 O C for 30 minutes before being placed in a freeze drier cooled to -20 O C and allowed to completely lyophilise under vacuum. For reconstitution, lyophilised samples were heated to 37 O C for 30 minutes and then 1ml sterile Milli-Q water at 37 O C was added. Samples were then vigorously vortexed before being passed through a
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9 0.2 µm filter to remove any particulates and to sterilise the sample prior to being bioassayed.
Statistical testing.
All experiments were repeated in triplicate at least three times. Data demonstrating differences in SI represent the mean % of fungal growth from each experiment compared to 100% growth of the positive control. All error bars express the arithmetic mean of three repeats, ± S.E.M. Differences between sample absorbance at t0 and t mid-log were assessed for significance by stacking all experimental data (omitting outliers) with n = ≥6 in all experiments. The two-tailed unpaired Students t-test was then used with P ≤0.05 being determined to be significant. 
Analysis of physiochemical properties of antifungal activity in nES.
The antifungal components of L. sericata nES were found to be remarkably thermally stable ( Figure 3 ) retaining activity across all temperatures investigated. Interestingly, activity was found to significantly increase after treatment at 50 O C for 15, 30 and 60 minutes and there was found to be no significant difference in nES activity when heated to 100 O C for 15 minutes, but there was a very highly significant increase in activity after treatment of nES at 100 O C for 60 minutes. These findings indicate that nES becomes more active after exposure to higher temperatures for longer periods of time. The antifungal activity of nES was also stable after repeated freeze-thawing, retaining significant antifungal activity after ten such 
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cycles ( Figure 4) . Although there was a slight decrease in the SI between untreated nES and nES which had been repeatedly frozen and thawed, there was no significant difference in the activity between the two samples (P >0.05). Antifungal activity was also retained by L. sericata nES after storage at room temperature for 24 hours, 48 hours, 7 days and 14 days (Figure 4 ). However storage of nES for 14 days at room temperature did show a significant increase in antifungal activity.
Determination of antifungal activity in L. sericata ES fractions.
Incubation with L. sericata ES fractions revealed that there was significant inhibition of fungal growth against all fungal species tested ( Figure 5a ). Although all fungal species were inhibited at t mid-log, there were changes in growth profiles of different fungal species. For example, both ES >10 and ES 10-0.5 ( Figure 5b ) were able to inhibit C. albicans growth at t mid-log. However, growth increased at a more rapid rate after 20 hours of incubation in the ES 10-0.5 sample whereas in the sample incubated with ES >10 a small increase in fungal growth was seen after 25 hours. Strong antifungal activity was found in the ES <0.5 fraction (Figure 5c ), often comparable to the activity seen in unfractionated nES, but stronger than the activity detected in the ES >10 fraction, as indicated by the lower SI values (Figure 5a ). Although there was no significant difference in activity between ES <0.5 and ES 10-0.5 treated C. krusei and S. cerevisiae (P >0.05), ES <0.5 was found to inhibit fungal growth for a longer period of time than the ES 10-0.5 fraction (Figure 5b ).
Analysis of physiochemical properties of antifungal activity present in ES <0.5.
Thermal stability testing of the ES <0.5 fraction revealed that very strong antifungal activity was maintained after heating between 50 O C and 100 O C for 60 minutes as well as 10 
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cycles of freezing and thawing and this activity significantly increased after 14 days storage at room temperature ( Figure 6 ). However, all fractions of ES <0.5 exposed to different conditions still retained the potent activity shown in untreated ES <0.5 ( Figure 6 ).
Lyophilisation of ES <0.5.
ES <0.5 also appeared to retain significant antifungal activity after lyophilisation, with lyophilised ES <0.5 reconstituted in Milli-Q water (x10 concentrated) completely inhibiting C.
albicans growth for up to 30 hours ( Figure 6 ).
Determination of antifungal activity in L. sericata L1 ES fractions.
Following incubation with all L. sericata L1 ES fractions, there was found to be no significant inhibition of fungal growth against C. albicans (supplementary material figures 1 and 2), indicating that neither L1 ES >10 , L1 ES 10-0.5 , or L1 ES <0.5 were able to inhibit normal C.
albicans growth.
Discussion
The antimicrobial properties of many insects including maggot ES have been widely demonstrated against numerous species of bacteria (9, 11, 22) , viruses (23) and fungal pathogens (16) (17) (18) , although to our knowledge, this is the first time that antifungal activity against several Candida and saccharomyces spp. has been demonstrated and investigated in L. sericata nES and its fractions (according to molecular weight). Using the OD assay, a high degree of antifungal activity was detected in all ES fractions. The activity seen in the higher molecular weight fractions of ES >10 and ES 10-0.5 is most likely due to the presence of large (>0.5 kDa) antifungal molecules/peptides, perhaps including the recently reported lucimycin (17) . The activity seen in these fractions could also be derived from other broad spectrum antimicrobial peptides. Drosomycin, isolated from Drosophila melanogaster (25) is one such antimicrobial peptide which shows activity against fungi and bacteria. The antifungal activity seen in the ES <0.5 fraction however, is most certainly due to a novel, smaller M r compound of molecular weight of <0.5 kDa.
The high level of activity suggested by the OD assay can be demonstrated by the presence of negative SI values. In this study, we have presented a number of data with negative SI values, which were typically associated with samples demonstrating antifungal activity. These negative SI values resulted from a decrease in sample absorbance, below its 
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14 starting optical density. Decreases in absorbance due to aberration in instrumentation were ruled out by measuring the mean change in absorbance in each well over 18 hours at 30 O C using a 2x diluted ES 10-0.5 sample. This revealed that there was a mean increase in absorbance of 0.0 ± 0.0 (n = 192, CI = 4.4%) which could be attributable to the plate reader.
Decreases in absorbance (like those seen when fungi were exposed to ES fractions) however
were not observed. It is possible that the decreases in absorbance seen are associated with lysis of fungal cells and this could be confirmed following detailed analysis of the mode of action of the purified antifungal compounds present.
Differences observed between the CFU and OD assays can be explained by the nature of the different assays. For instance, in the CFU assay, C. albicans is incubated in the presence of nES or its fractions. These were then removed to allow growth to occur on an agar plate. Therefore, the CFU assay measures colony growth after the first incubation stage which takes place in the presence of the antifungal compound/test sample. Thus, during the second 24 hour growth period on the agar plate, any suppressive growth components which the fungi are exposed to during the first incubation stage are removed (through dilution)
and fungal growth appears to resume.
The OD assay however, in which the antifungal agents are present during the complete growth period appears to better demonstrate fungal growth kinetics during the first incubation stage of the CFU assay, as fungal growth can be monitored within the first 24 hours. Our data suggest that both the ES >10 and ES 10-0.5 fractions may be fungistatic in nature against C. albicans. Strong antifungal activity was seen during (OD assay) and following (CFU assay) treatment of fungal cells with the ES <0.5 fraction with a 100% reduction of fungal cells in the CFU assay, demonstrating fungicidal properties within the ES <0.5 (26) and an antimicrobial, β-alanyltyrosin (27) .
Interestingly, the antifungal activity of nES in this study appeared to increase after heating to 50 O C for 15 minutes compared to untreated nES, a finding also reported by
Bexfield et al., (8) who attributed this increase in activity to the abrogation of inhibition complexes and enhanced activation of the antibacterial factor. Further heating of nES also appeared to increase the antifungal activity, with nES also remaining stable after rapid freezing and thawing, as well as after prolonged incubation at room temperature. These findings support the view that there are small (<0.5 kDa) non-proteinaceous antifungal components present in nES.
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Strong antifungal activity was also retained by ES <0.5 after lyophilisation. Given that ES <0.5 appears to retain antifungal activity after freezing, it is perhaps not surprising that activity remains after lyophilisation. However the fact that the compound still retains activity after all water has been removed from the sample suggests that the compound is highly stable when subject to a variety of extreme treatments.
We also discovered that first instar larval nES possesses no detectable antifungal activity. This was surprising, considering that in nature, oviposition of L. sericata eggs occurs primarily on carrion and decaying organic matter (15) . Our finding that sterile late L2 and L3
larvae secrete strong antifungal components may suggest that L sericata larvae do not possess these antifungal components within the first few hours of hatching. L. sericata larvae do however appear to be resistant to cuticle degradation by fungal proteases, while adult L sericata promptly die when exposed to sporulating fungi (28) . It may be that during hatching, the protection provided by the cuticle is adequate in the initial stages of cadaver colonisation, with the excretion/secretion of antifungals coinciding with the fungal colonisers becoming more established.
Although the antibacterial properties of L. sericata ES have long been known, the antifungal properties have received less attention. Here we show the robust activity of L.
sericata nES and its fractions against several species of fungi, including C. albicans. Further work on the isolation and purification of the active component(s) of the ES <0.5 fraction is currently being undertaken with the aim of identifying and chemically defining the small, low M r antifungal found in L. sericata excretions/secretions. Once we have purified and isolated the antifungal compound its activity will be assessed against a greater range of fungal pathogens and MIC testing will be undertaken.
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All work was funded by the College of Human and Health Sciences, Swansea University. thawing and storage at room temperature, calculated by the OD assay and SI. There was found to be no significant difference in antifungal activity in nES samples which had been subjected to 10 cycles of freezing and thawing (n = 8) or storage at room temperature for up to seven days (n = 9).
However, a statistically significant increase in antifungal activity was seen in samples which had been incubated for 14 days at room temperature (P <0.001, n = 9). All SI values are relative to 100% growth of the positive growth control. This reduction in absorbance was found to be within the accepted 4.4% confidence value on two occasions. All SI values are relative to 100% growth of the positive growth control. Antifungal activity of nES was not found to be adversely affected by heating, still retaining significant activity despite exposure to extreme temperatures. Following heat treatment, there was generally found to be a significant increase in activity, compared to untreated nES (n = 9, 50 O C for 30 minutes, n = 8). There was however no significant difference in activity seen in the nES fraction heated to 100 O C for 15 minutes; * = P <0.05, ** = P <0.005, *** = P <0.001. Negative SI values represent a negative difference between samples t mid-log and t0. This reduction in absorbance was found to be within the accepted 4.4% confidence value. All SI values are relative to 100% growth of the positive growth control. 124x99mm (300 x 300 DPI) Figure 4 . Survival index of C. albicans after incubation with nES treated by 10 cycles of freezing and thawing and storage at room temperature, calculated by the OD assay and SI. There was found to be no significant difference in antifungal activity in nES samples which had been subjected to 10 cycles of freezing and thawing (n = 8) or storage at room temperature for up to seven days (n = 9). However, a statistically significant increase in antifungal activity was seen in samples which had been incubated for 14 days at room temperature (P <0.001, n = 9). All SI values are relative to 100% growth of the positive growth control. (A) Survival index of Candida and Saccharomyces spp during incubation with nES and its fractions, calculated by the OD assay and SI. Both nES and its fractions possess strong antifungal properties, as indicated by the low SI across all fractions and fungal species tested compared to 100% growth of the positive growth control. There was also found to be a very highly significant difference in fungal growth of the positive control (100%) and fungi treated with ES fractions (P <0.001, n = ≥6). A high level of sensitivity was seen by C. albicans against ES>10 and ES10-0.5 fractions (B), as well as ES<0.5 (C). 124x162mm (300 x 300 DPI) Figure 6 . Survival index of C. albicans after incubation with treated ES<0.5, determined by the OD assay and SI. As seen with nES, heating, freeze/thawing, storage at room temperature for 14 days and lyophilisation appeared to have no significant negative effect on the antifungal activity of L. sericata ES<0.5.
Negative SI values represent a negative difference between samples t mid-log and t0. This reduction in absorbance was found to be within the accepted 4.4% confidence value on two occasions. All SI values are relative to 100% growth of the positive growth control. 124x100mm (300 x 300 DPI)
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Supplementary Methodology
Collections of larval secretions. hours (depending on species tested) to obtain optimum growth curves demonstrating all phases of growth up to stationary phase, with the optical density at 550 (OD 550 ) being measured hourly
Briefly
